Researchers have found promise in a Type 1 diabetes drug that was left for dead in 2010.
Read More »Craig Idlebrook
The U.S. government has changed the way it reimburses for many diabetes supplies. Will this spark innovation or crisis in…
Read More »The FDA announces Nova Diabetes Care is recalling 62 million glucose test strips. Could this recall have been prevented by…
Read More »GlaxoSmithKline agrees to pay $229 million to nine states to settle claims over Avandia, its once-popular diabetes drug. At the…
Read More »Researchers are trying to determine how to utilize compounds in marijuana to control insulin levels. A U.K. drugmaker reports promise…
Read More »